Infection with Leishmania major induces a cellular stress response in macrophages

Alessandra A Filardy1, Ana Caroline Costa-da-Silva1, Carolina M Koeller1

  • 1Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Plos One
|January 14, 2014
PubMed

Insights

Leishmania major infection triggers cellular stress responses in resident macrophages, increasing reactive oxygen species and JNK activation. These pathways promote parasite survival and replication within host cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Leishmania major infects macrophages, the primary host cells.
  • Understanding early host-pathogen interactions is crucial for developing treatments.

Purpose of the Study:

  • To investigate early cellular responses in macrophages infected with Leishmania major.
  • To elucidate the role of reactive oxygen species (ROS) and stress-activated protein kinases/c-Jun N-terminal kinases (SAPK/JNK) pathways in Leishmania infection.

Main Methods:

  • Infection of C57/BL6 mouse-derived resident and inflammatory peritoneal macrophages with Leishmania major.
  • Measurement of ROS production, SAPK/JNK activation, FasL expression, and cytokine/chemokine secretion.
  • Treatment with antioxidants (deferoxamine, N-acetylcysteine) and a JNK inhibitor (SP600125).
  • Assessment of intracellular parasite replication.

Main Results:

  • Leishmania major infection increased ROS production and SAPK/JNK activation in resident macrophages, but not inflammatory ones.
  • Infected resident macrophages secreted various pro-inflammatory cytokines and chemokines.
  • Antioxidants and JNK inhibition reduced ROS generation, JNK activation, KC secretion, and intracellular parasite replication.

Conclusions:

  • Leishmania major infection induces a rapid cellular stress response in resident macrophages.
  • The ROS and SAPK/JNK pathways are involved in promoting parasite survival and replication within macrophages.
  • Targeting these pathways may offer therapeutic strategies against leishmaniasis.